cognitive cybersecurity intelligence
Photo/Shutterstock
Visiox Pharma, LLC has received notification from the U.S. Food and Drug Administration (FDA) that the agency has completed its filing review and accepted for filing the New Drug Application (NDA) for PDP-716 (0.35% brimonidine tartrate) for the…
Source: www.labiotech.eu – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Bookworm to Stately Taurus Using the Unit 42 Attribution Framework Palo Alto Networks
A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift
Press Ganey Associates Data Breach Lawsuit Investigation Claim Depot
John Blacksmith reports: Verily, owned by Alphabet, is facing a lawsuit filed by an ex-employee who alleges the misuse of the personally identifiable health information
